Brought to you by 
EndoGastric Solutions closes $32mm Series C round
28 Feb 2006
Executive Summary
EndoGastric Solutions (formerly EsophyX; medical devices for gastrointestinal disorders) brought in $32mm with its Series C private financing led by Chicago Growth Partners. Other first-time backer Oakwood Medical Investors was joined by returning shareholders MPM Capital, Advanced Technology Ventures, and Foundation Medical Partners. The company will use the funding to continue Phase II trials of its lead product EsophyX for GERD and to develop additional candidates for obesity.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
EndoGastric Solutions closes $32mm Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice